J9323
J9323 – Injection, pemetrexed ditromethamine, 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 2 NDCs crosswalked
📋 J9323 summary
J9323 is a HCPCS Level II J-code used to bill pemetrexed ditromethamine, 10 mg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J9323: Pemetrexed(J9323)
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ9323
DescriptorInjection, pemetrexed ditromethamine, 10 mg
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs2
Data periodNot available in current dataset
Last updatedSource date not available
🧾 Billing & reimbursement HCPCS · CMS
Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionInjection, pemetrexed ditromethamine, 10 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2023-07-01
Date added2023-07-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J9323 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J9323 CROSSWALKED NDCs
2 NDCs map to J9323. Bill units = how many HCPCS units one package represents.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 00409-1060-01 | PEMETREXED (SDV,PF,LATEX-FREE) 100 MG | Unknown | — | — | 10 | — | — | PDAC |
| 00409-1061-01 | PEMETREXED (SDV,PF,LATEX-FREE) 500 MG | Unknown | — | — | 50 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2025 (Q1-Q4)
Total Part B spend
$78.7K
Claims
132
Beneficiaries
34
Spend / beneficiary
$2,314.24
Spend / claim
$596.09
Where J9323 ranks among Part B drugs · 2025 (Q1-Q4) · neighbors ±5
Total spending — #702 of 918
#697
CORTROSYN* J0834
$87K
#698
MULTIHANCE MULTIPACK A9578
$86.1K
#699
FETROJA J0699
$85.9K
#700
DAPTOMYCIN(J0873) J0873
$84K
#701
CLONIDINE HCL* J0735
$83.3K
#702
PEMETREXED(J9323) J9323
$78.7K
#703
MOXIFLOXACIN J2280
$76.1K
#704
IBANDRONATE SODIUM J1740
$75.3K
#705
COMIRNATY (5-11Y)* 91319
$72.8K
#706
MIRCERA J0888
$71.9K
#707
ENOXAPARIN SODIUM* J1650
$69.3K
Total claims — #764 of 918
#759
FLUMIST * 90660
138
#760
CALCITONIN-SALMON* J0630
136
#761
CHLOROPROCAINE HCL* J2401
135
#762
SIVEXTRO J3090
135
#763
PROGRAF(J7525)* J7525
132
#764
PEMETREXED(J9323) J9323
132
#765
BIZENGRI J9382
130
#766
DILTIAZEM HCL-0.9% N... J1163
129
#767
EVOMELA J9246
129
#768
ABILIFY ASIMTUFII J0402
128
#769
FLUCONAZOLE-NACL J1450
128
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (1)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2025 (Q1-Q4) | $78.7K | 34 | 132 | $2,314.24 | $596.09 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
2 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2025
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J9323 billing FAQ
What is HCPCS code J9323?
J9323 is a HCPCS Level II J-code used to bill Injection, pemetrexed ditromethamine, 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J9323?
2 NDCs currently map to J9323 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9323 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.